Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging

Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the...

Full description

Saved in:
Bibliographic Details
Published inAging medicine Vol. 4; no. 3; pp. 214 - 220
Main Authors Palmer, Raymond D., Elnashar, Magdy Mahmoud, Vaccarezza, Mauro
Format Journal Article
LanguageEnglish
Published Australia John Wiley & Sons, Inc 01.09.2021
John Wiley and Sons Inc
Wiley
Subjects
Adenosine diphosphate
aging
Biology
Enzymes
Human subjects
Metabolism
Metabolites
nicotinamide
nicotinamide adenine dinucleotide
nicotinamide mononucleotide
nicotinamide riboside
nicotinic acid
reduced nicotinamide mononucleotide
Review
nicotinamide adenine dinucleotide
reduced nicotinamide mononucleotide
nicotinamide
aging
nicotinamide mononucleotide
nicotinamide riboside
nicotinic acid
Online AccessGet full text

Cover

Abstract Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature. Effects of NAD‐boosting molecules on human physiology. NAD+ boosters have a substantial effect on the well‐being and survival of mammals.
AbstractList Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature. Effects of NAD‐boosting molecules on human physiology. NAD + boosters have a substantial effect on the well‐being and survival of mammals.
Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature.Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature.
Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature.
Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature. Effects of NAD‐boosting molecules on human physiology. NAD+ boosters have a substantial effect on the well‐being and survival of mammals.
Abstract Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and tissue types via an endogenous and exogenous influence. NAD levels are demonstrated to decline with age and therefore measures to counteract the waning of NAD have been devised. A number of NAD precursor candidates such as nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), the reduced form of nicotinamide mononucleotide (NMNH), nicotinic acid (NA) nicotinamide (NAM), and dihydronicotinamide riboside (DNR) increase NAD levels in vitro and in vivo. This discussion will focus on the precursors NR, NMN, NMNH, and DNR in the upregulation of NAD. There are many publications on NAD precursors as it has become popular for human consumption in recent years due to its vital importance to the general consumer. However, there is no consensus between researchers and this was the aim of this review, to determine and discuss their areas of agreement versus disagreement, to highlight the gaps in research, and to give recommendations for future work. Bioavailability and potency of NR, NMNH, NMN, and DNR is also examined on the light of the most recent literature.
Author Elnashar, Magdy Mahmoud
Vaccarezza, Mauro
Palmer, Raymond D.
AuthorAffiliation 2 School of Medicine Faculty of Health Sciences Curtin University Perth WA Australia
1 Longevity Experts Helium‐3 Biotech Perth WA Australia
3 Center of Excellence Department of Polymers National Research Centre Cairo Egypt
AuthorAffiliation_xml – name: 1 Longevity Experts Helium‐3 Biotech Perth WA Australia
– name: 2 School of Medicine Faculty of Health Sciences Curtin University Perth WA Australia
– name: 3 Center of Excellence Department of Polymers National Research Centre Cairo Egypt
Author_xml – sequence: 1
  givenname: Raymond D.
  orcidid: 0000-0003-1898-0935
  surname: Palmer
  fullname: Palmer, Raymond D.
  email: ray.palmer@longevityexperts.com
  organization: Helium‐3 Biotech
– sequence: 2
  givenname: Magdy Mahmoud
  surname: Elnashar
  fullname: Elnashar, Magdy Mahmoud
  organization: National Research Centre
– sequence: 3
  givenname: Mauro
  surname: Vaccarezza
  fullname: Vaccarezza, Mauro
  organization: Curtin University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34553119$$D View this record in MEDLINE/PubMed
BookMark eNp9kktr3DAUhU1JaR7Npj-gGLoJgZleyZItbwohtGkgfSzatZCla48GW3IlOyX_vppxUpJQutLjfudwpHuPswPnHWbZGwJrAkDfq26ga0JJBS-yI8oqvoKihINH-8PsNMYtAJC6rsuCvsoOC8Z5QUh9lIXvAfUcog-59sOogo3exbxN52mD-TwG7OZeTda73Le5s9pP1qnBGsyVQWcd5sa6WfeYCgbX-Vd_i32uxjF4pTe4eDU4TRhy1VnXvc5etqqPeHq_nmQ_P338cfl5dfPt6vry4maluQBYVcAENZUCKJWgJTVlzRXwWu_eqgmhqAw3RVUzXdUtZ6A1Ni2vBCuZKIUpTrLrxdd4tZVjsIMKd9IrK_cXPnRShcmm5JIS3aBAURRJjrpQgihDRcMoM3XbVMnrw-I1zs2ARqObguqfmD6tOLuRnb-VgjFW8zIZnN0bBP9rxjjJwUaNfa8c-jlKyisuCqDAE_ruGbr1c3Dpq3YUFZxygES9fZzob5SH1iYAFkAHH2PAVmo77RuZAtpeEpC7AZK7AZL7AUqS82eSB9d_wmSBf9se7_5DyourL3TR_AHjRtWn
CitedBy_id crossref_primary_10_3389_fonc_2022_954512
crossref_primary_10_1016_j_enzmictec_2025_110633
crossref_primary_10_1002_agm2_12193
crossref_primary_10_1016_j_bbabio_2022_148588
crossref_primary_10_3389_fnut_2024_1359176
crossref_primary_10_3389_fphar_2021_749727
crossref_primary_10_7759_cureus_65961
crossref_primary_10_3390_antiox12020376
crossref_primary_10_3390_cells13171469
crossref_primary_10_3390_ijms232314711
crossref_primary_10_1016_j_bcp_2022_114946
crossref_primary_10_3390_cells12192396
Cites_doi 10.1038/s41514-017-0016-9
10.1016/j.cmet.2018.02.011
10.1073/pnas.1509930112
10.1089/ars.2007.1672
10.1021/acs.jproteome.0c01037
10.1016/S0021-9258(18)94230-4
10.3390/biom9010034
10.1016/S0014-5793(01)02180-9
10.1016/j.lfs.2018.09.015
10.1016/j.cmet.2019.05.015
10.1074/jbc.RA118.005772
10.1016/j.cmet.2016.05.022
10.1371/journal.pone.0042357
10.1038/nrm.2016.93
10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L
10.21203/rs.3.rs-87047/v1
10.1146/annurev.pathol.4.110807.092250
10.1016/j.molmet.2019.09.013
10.1186/s40170-016-0145-9
10.1038/ncomms13103
10.1038/35001622
10.1093/emboj/cdg209
10.1016/j.stem.2019.02.012
10.1098/rsbm.1972.0023
10.1038/s42255-018-0009-4
10.1096/fj.202001826R
10.1016/j.cell.2013.11.037
10.1038/s42255-019-0085-0
10.1146/annurev.biochem.73.011303.073651
10.1016/j.mehy.2007.01.029
10.1371/journal.pone.0186459
10.1155/2019/2641712
10.1016/S0092-8674(04)00416-7
10.1016/j.cell.2018.02.008
10.1177/2042533313479197
10.1038/ncomms12948
10.1016/j.cmet.2018.03.018
10.1093/ajhp/60.suppl_2.S9
10.1161/CIRCRESAHA.118.312498
10.1016/j.tibs.2004.01.007
10.1016/j.cmet.2017.11.002
10.1126/science.aac4854
10.1186/s12970-016-0143-x
ContentType Journal Article
Copyright 2021 The Authors. published by Beijing Hospital and John Wiley & Sons Australia, Ltd.
2021 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd.
2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by Beijing Hospital and John Wiley & Sons Australia, Ltd.
– notice: 2021 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/agm2.12170
DatabaseName Wiley Online Library
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate PALMER et al
EISSN 2475-0360
EndPage 220
ExternalDocumentID oai_doaj_org_article_21cbe8e833784ec3a81ad28b424d9fb7
PMC8444956
34553119
10_1002_agm2_12170
AGM212170
Genre reviewArticle
Journal Article
Review
GroupedDBID 0R~
1OC
24P
7X7
8FI
8FJ
AAHHS
ABUWG
ACCFJ
ACCMX
ACGFS
ACXQS
ADBBV
ADKYN
ADPDF
ADZMN
ADZOD
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AVUZU
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
EBS
EIHBH
EJD
FYUFA
GROUPED_DOAJ
HMCUK
M~E
O9-
OK1
OVD
OVEED
PIMPY
PQQKQ
PROAC
RPM
TEORI
UKHRP
WIN
AAYXX
CITATION
PHGZM
PHGZT
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c5800-70482d7a006a8262d695a059c2170c112ead5d3794c79f540ccebf578464868d3
IEDL.DBID 7X7
ISSN 2475-0360
IngestDate Wed Aug 27 01:31:10 EDT 2025
Thu Aug 21 18:29:27 EDT 2025
Tue Aug 05 10:46:23 EDT 2025
Fri Jul 25 07:17:17 EDT 2025
Wed Feb 19 02:08:59 EST 2025
Tue Jul 01 02:39:48 EDT 2025
Thu Apr 24 23:10:16 EDT 2025
Wed Jan 22 16:27:39 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords nicotinamide adenine dinucleotide
reduced nicotinamide mononucleotide
nicotinamide
aging
nicotinamide mononucleotide
nicotinamide riboside
nicotinic acid
Language English
License Attribution-NonCommercial-NoDerivs
2021 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5800-70482d7a006a8262d695a059c2170c112ead5d3794c79f540ccebf578464868d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-1898-0935
OpenAccessLink https://www.proquest.com/docview/2572852500?pq-origsite=%requestingapplication%
PMID 34553119
PQID 2572852500
PQPubID 4365298
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_21cbe8e833784ec3a81ad28b424d9fb7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8444956
proquest_miscellaneous_2575830205
proquest_journals_2572852500
pubmed_primary_34553119
crossref_citationtrail_10_1002_agm2_12170
crossref_primary_10_1002_agm2_12170
wiley_primary_10_1002_agm2_12170_AGM212170
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2021
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: September 2021
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Milton
– name: Hoboken
PublicationTitle Aging medicine
PublicationTitleAlternate Aging Med (Milton)
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2019; 2019
2019; 9
2013; 4
2021; 20
2017; 3
2004; 29
2019; 30
2019; 1
2018; 123
2002; 32
2008; 10
2016; 17
2018; 27
2016; 13
2015; 350
2016; 4
2021; 35
2016; 7
2001; 492
2004; 73
2018; 173
2020
2000; 403
2019; 24
2015; 112
2018; 211
1989; 264
2017; 12
2013; 155
2014
2003; 60
2019; 294
2012; 7
2010; 5
2004; 117
1972; 18
2007; 69
2016; 23
2003; 22
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
Harden A (e_1_2_8_5_1) 2014
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_41_1
e_1_2_8_40_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 73
  start-page: 417
  year: 2004
  end-page: 435
  article-title: The Sir2 family of protein deacetylases
  publication-title: Annu Rev Biochem
– volume: 27
  start-page: 1067‐
  year: 2018
  end-page: 1080
  article-title: Quantitative analysis of NAD synthesis‐breakdown fluxes in brief
  publication-title: Cell Metab
– volume: 7
  year: 2016
  article-title: Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
  publication-title: Nat Commun
– volume: 35
  start-page: 1
  issue: 4
  year: 2021
  end-page: 17
  article-title: Reduced nicotinamide mononucleotide is a new and potent nad+ precursor in mammalian cells and mice
  publication-title: FASEB J
– volume: 112
  start-page: 8714
  issue: 28
  year: 2015
  end-page: 8719
  article-title: High‐fat diet and FGF21 cooperatively promote aerobic thermogenesis in mtDNA mutator mice
  publication-title: Proc Natl Acad Sci U S A
– volume: 13
  start-page: 32
  issue: 1
  year: 2016
  article-title: The NAD+ precursor nicotinamide riboside decreases exercise performance in rats
  publication-title: J Int Soc Sports Nutr
– volume: 1
  start-page: 47
  issue: 1
  year: 2019
  end-page: 57
  article-title: Slc12a8 is a nicotinamide mononucleotide transporter
  publication-title: Nat Metab
– volume: 2019
  start-page: 1
  year: 2019
  end-page: 15
  article-title: PARP1 and poly(ADP‐ribosyl)ation signaling during autophagy in response to nutrient deprivation
  publication-title: Oxid Med Cell Longev
– volume: 173
  start-page: 74
  issue: 1
  year: 2018
  end-page: 89
  article-title: Impairment of an endothelial NAD+‐H2S signaling network is a reversible cause of vascular aging
  publication-title: Cell
– volume: 32
  start-page: 3225
  issue: 11
  year: 2002
  end-page: 3234
  article-title: Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAF biosynthesis
  publication-title: Eur J Immunol
– volume: 403
  start-page: 795
  issue: 6771
  year: 2000
  end-page: 800
  article-title: Transcriptional silencing and longevity protein Sir2 is an NAD‐dependent histone deacetylase
  publication-title: Nature
– volume: 294
  start-page: 9295
  issue: 23
  year: 2019
  end-page: 9307
  article-title: Dihydronicotinamide riboside is a potent NAD concentration enhancer in vitro and in vivo
  publication-title: J Biol Chem
– volume: 7
  start-page: 13103
  year: 2016
  article-title: NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
  publication-title: Nat Commun
– volume: 69
  start-page: 618
  issue: 3
  year: 2007
  end-page: 628
  article-title: Pellagra: a clue as to why energy failure causes diseases?
  publication-title: Med Hypotheses
– volume: 4
  start-page: 204253331347919
  issue: 6
  year: 2013
  article-title: Using mixed methods in health research
  publication-title: JRSM Short Rep
– year: 2014
– volume: 7
  issue: 7
  year: 2012
  article-title: Age‐associated changes in oxidative stress and NAD+ metabolism in human tissue
  publication-title: PLoS One
– volume: 123
  start-page: 868
  issue: 7
  year: 2018
  end-page: 885
  article-title: Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases
  publication-title: Circ Res
– volume: 117
  start-page: 495
  issue: 4
  year: 2004
  end-page: 502
  article-title: Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a preiss‐handler independent route to NAD+ in fungi and humans
  publication-title: Cell
– volume: 350
  start-page: 1208
  issue: 6265
  year: 2015
  end-page: 1213
  article-title: NAD+ in aging, metabolism, and neurodegeneration
  publication-title: Science
– volume: 29
  start-page: 111
  issue: 3
  year: 2004
  end-page: 118
  article-title: The new life of a centenarian: signalling functions of NAD(P)
  publication-title: Trends Biochem Sci
– volume: 211
  start-page: 1
  year: 2018
  end-page: 7
  article-title: Nicotinamide riboside induces a thermogenic response in lean mice
  publication-title: Life Sci
– volume: 492
  start-page: 95
  issue: 1–2
  year: 2001
  end-page: 100
  article-title: Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis
  publication-title: FEBS Lett
– volume: 3
  start-page: 17
  issue: 1
  year: 2017
  article-title: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double‐blind, placebo‐controlled study
  publication-title: npj Aging Mech Dis
– volume: 20
  start-page: 2596
  issue: 5
  year: 2021
  end-page: 2606
  article-title: Reduced nicotinamide mononucleotide (NMNH) potently enhances NAD+ and suppresses glycolysis, the TCA cycle, and cell growth
  publication-title: J Proteome Res
– volume: 17
  start-page: 679
  issue: 11
  year: 2016
  end-page: 690
  article-title: Slowing ageing by design: the rise of NAD+ and sirtuin‐activating compounds
  publication-title: Nat Rev Mol Cell Biol
– volume: 18
  start-page: 629
  year: 1972
  end-page: 699
  article-title: Otto Heinrich Warburg, 1883–1970
  publication-title: Biogr Mem Fellows R Soc
– volume: 5
  start-page: 253
  year: 2010
  end-page: 295
  article-title: Mammalian sirtuins: biological insights and disease relevance
  publication-title: Annu Rev Pathol Mech Dis
– year: 2020
– volume: 27
  start-page: 513
  issue: 3
  year: 2018
  end-page: 528
  article-title: NAD+ intermediates: the biology and therapeutic potential of NMN and NR
  publication-title: Cell Metab
– volume: 23
  start-page: 965
  issue: 6
  year: 2016
  end-page: 966
  article-title: Why NAD+ declines during aging: it’s destroyed
  publication-title: Cell Metab
– volume: 27
  start-page: 529
  issue: 3
  year: 2018
  end-page: 547
  article-title: Therapeutic potential of NAD‐boosting molecules: the in vivo evidence
  publication-title: Cell Metab
– volume: 9
  start-page: 34
  issue: 1
  year: 2019
  article-title: Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule
  publication-title: Biomolecules
– volume: 10
  start-page: 179
  issue: 2
  year: 2008
  end-page: 206
  article-title: NAD+/NADH and NADP+/NADPH in cellular functions and cell death: Regulation and biological consequences
  publication-title: Antioxidants Redox Signal
– volume: 22
  start-page: 1953
  issue: 9
  year: 2003
  end-page: 1958
  article-title: Functional aspects of protein mono‐ADP‐ribosylation
  publication-title: EMBO J
– volume: 155
  start-page: 1624
  issue: 7
  year: 2013
  end-page: 1638
  article-title: Declining NAD+ induces a pseudohypoxic state disrupting nuclear‐mitochondrial communication during aging
  publication-title: Cell
– volume: 4
  start-page: 5
  issue: 1
  year: 2016
  article-title: Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism
  publication-title: Cancer Metab
– volume: 24
  start-page: 405
  issue: 3
  year: 2019
  end-page: 418
  article-title: The NAD‐booster nicotinamide riboside potently stimulates hematopoiesis through increased mitochondrial clearance
  publication-title: Cell Stem Cell
– volume: 30
  start-page: 192
  year: 2019
  end-page: 202
  article-title: A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
  publication-title: Mol Metab
– volume: 264
  start-page: 1608
  issue: 3
  year: 1989
  end-page: 1615
  article-title: Structural determination of a cyclic metabolite of NAD+ with intracellular Ca2+‐mobilizing activity
  publication-title: J Biol Chem
– volume: 30
  start-page: 329
  issue: 2
  year: 2019
  end-page: 342
  article-title: Extracellular vesicle‐contained eNAMPT delays aging and extends lifespan in mice
  publication-title: Cell Metab
– volume: 12
  issue: 12
  year: 2017
  article-title: An open‐label, non‐randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers
  publication-title: PLoS One
– volume: 60
  start-page: S9
  issue: 13 Suppl 2
  year: 2003
  end-page: S14
  article-title: Overview of niacin formulations: differences in pharmacokinetics, efficacy, and safety
  publication-title: Am J Health Syst Pharm
– volume: 1
  start-page: 660
  issue: 7
  year: 2019
  end-page: 661
  article-title: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter
  publication-title: Nat Metab
– ident: e_1_2_8_21_1
  doi: 10.1038/s41514-017-0016-9
– ident: e_1_2_8_2_1
  doi: 10.1016/j.cmet.2018.02.011
– ident: e_1_2_8_32_1
  doi: 10.1073/pnas.1509930112
– ident: e_1_2_8_8_1
  doi: 10.1089/ars.2007.1672
– ident: e_1_2_8_17_1
– ident: e_1_2_8_43_1
  doi: 10.1021/acs.jproteome.0c01037
– volume-title: The Alcoholic Ferment of Yeast‐Juice. Part II–The Coferment of Yeast‐Juice
  year: 2014
  ident: e_1_2_8_5_1
– ident: e_1_2_8_9_1
  doi: 10.1016/S0021-9258(18)94230-4
– ident: e_1_2_8_30_1
  doi: 10.3390/biom9010034
– ident: e_1_2_8_14_1
  doi: 10.1016/S0014-5793(01)02180-9
– ident: e_1_2_8_33_1
  doi: 10.1016/j.lfs.2018.09.015
– ident: e_1_2_8_42_1
  doi: 10.1016/j.cmet.2019.05.015
– ident: e_1_2_8_44_1
  doi: 10.1074/jbc.RA118.005772
– ident: e_1_2_8_4_1
  doi: 10.1016/j.cmet.2016.05.022
– ident: e_1_2_8_39_1
  doi: 10.1371/journal.pone.0042357
– ident: e_1_2_8_45_1
  doi: 10.1038/nrm.2016.93
– ident: e_1_2_8_15_1
  doi: 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L
– ident: e_1_2_8_31_1
  doi: 10.21203/rs.3.rs-87047/v1
– ident: e_1_2_8_19_1
  doi: 10.1146/annurev.pathol.4.110807.092250
– ident: e_1_2_8_27_1
  doi: 10.1016/j.molmet.2019.09.013
– ident: e_1_2_8_6_1
  doi: 10.1186/s40170-016-0145-9
– ident: e_1_2_8_29_1
  doi: 10.1038/ncomms13103
– ident: e_1_2_8_13_1
  doi: 10.1038/35001622
– ident: e_1_2_8_11_1
  doi: 10.1093/emboj/cdg209
– ident: e_1_2_8_34_1
  doi: 10.1016/j.stem.2019.02.012
– ident: e_1_2_8_7_1
  doi: 10.1098/rsbm.1972.0023
– ident: e_1_2_8_38_1
  doi: 10.1038/s42255-018-0009-4
– ident: e_1_2_8_28_1
  doi: 10.1096/fj.202001826R
– ident: e_1_2_8_40_1
  doi: 10.1016/j.cell.2013.11.037
– ident: e_1_2_8_41_1
  doi: 10.1038/s42255-019-0085-0
– ident: e_1_2_8_18_1
  doi: 10.1146/annurev.biochem.73.011303.073651
– ident: e_1_2_8_37_1
  doi: 10.1016/j.mehy.2007.01.029
– ident: e_1_2_8_24_1
  doi: 10.1371/journal.pone.0186459
– ident: e_1_2_8_12_1
  doi: 10.1155/2019/2641712
– ident: e_1_2_8_16_1
  doi: 10.1016/S0092-8674(04)00416-7
– ident: e_1_2_8_25_1
  doi: 10.1016/j.cell.2018.02.008
– ident: e_1_2_8_36_1
  doi: 10.1177/2042533313479197
– ident: e_1_2_8_22_1
  doi: 10.1038/ncomms12948
– ident: e_1_2_8_26_1
  doi: 10.1016/j.cmet.2018.03.018
– ident: e_1_2_8_35_1
  doi: 10.1093/ajhp/60.suppl_2.S9
– ident: e_1_2_8_20_1
  doi: 10.1161/CIRCRESAHA.118.312498
– ident: e_1_2_8_10_1
  doi: 10.1016/j.tibs.2004.01.007
– ident: e_1_2_8_46_1
  doi: 10.1016/j.cmet.2017.11.002
– ident: e_1_2_8_3_1
  doi: 10.1126/science.aac4854
– ident: e_1_2_8_23_1
  doi: 10.1186/s12970-016-0143-x
SSID ssj0001999632
Score 2.2365048
SecondaryResourceType review_article
Snippet Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular compartments and...
Abstract Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every human cell and regulates a number of systems across multiple cellular...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 214
SubjectTerms Adenosine diphosphate
aging
Biology
Enzymes
Human subjects
Metabolism
Metabolites
nicotinamide
nicotinamide adenine dinucleotide
nicotinamide mononucleotide
nicotinamide riboside
nicotinic acid
reduced nicotinamide mononucleotide
Review
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4hDhWXqg8oaWnlqlxACmxsJ3GOtCpFlRZxAImb5Vco0jZB2d3-_s442WhXIHrpLYotx_HMeD7b428ADl1FoDhkaZWrSYr-uE6NMllquLcF4qNQObqNPL0sLm7kz9v8di3VF8WE9fTA_cCd8szZoIISolQyOGFUZjxXVnLpq9rGe-To89YWU3F3hXC84CMfKT81d785USlQVuI1DxSJ-p9Cl4-DJNfBa_Q-56_g5QAb2Vnf3dewFZo38GI6HIy_he6qo43zedsxN2YWnDNEpAwRHls-dH3OeZQCa2vWoPwX95SL3gdmcOrBRhh6MSI3xgIfTthl-yfM2IpyPPRt2Xj5h8XMRrtwc_79-ttFOqRTSB3KYZKWaKzclwbtzOCigvuiyg2iK0eD4hB3oVLlXqCBurKqEck5F2yNFi0LqQrlxR5sN20T9oGVSgQpSqcoBtVKRJ2ZL4zNslB7gYveBI5WQ6zdwDVOKS9mumdJ5prEoaM4Evgy1n3oGTaerPWVJDXWIFbs-AJ1RQ-6ov-lKwkcrOSsB1Oda5yzuKLDXfzG57EYjYxOTkwT2mWskxNR2iRP4F2vFmNPhMxxHsuqBMoNhdno6mZJc_8rEnkrKWl9msBxVK1nfl-f_Zjy-PT-fwzEB9jhFJsTY-UOYHvRLcNHBFcL-yna0V8cgSJr
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Wiley Online Library
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB5CCqWX0nfdpEWlvbTgZi3Jlgy9pKVpKGzIoYHchF5OAqkdvLv9_ZmRvd4uDYXeltWsV9bMJ316fQPw3tdEimOR16We5TgeN7nVtsgtD65CfhRrT7eR5yfV8Zn8cV6e78Dn9V2YQR9iWnAjZKT-mgBu3eJgIxpqL35x0kZQOGG_R3drSTmfy9PNCgtx-ZShjEtV5thVzyZ9Un6w-fnWiJSE--9im38fmvyTzKbR6OgRPBxpJDsc_P4YdmL7BO7Px43yp9Cf9rSQvuh65qdMgwuGDJUh42Orm37IQY9eYV3DWoyH5RXlpg-RWeyK8CEMRzUSO8aCED-xk-53vGZrCfI4PMuly0AsZTp6BmdH335-Pc7H9Aq5R7_McoXg5UFZxJ3FSQYPVV1aZFueGsUjD8MgK4NAwHpVN8jsvI-uQYRjU-tKB_EcdtuujS-BKS2iFMprOpPqJLLQIlTWFUVsgsBJcAYf1k1s_Kg9Tikwrs2gmswNucMkd2TwbrK9GRQ37rT6Qp6aLEglO33R9RdmBJ3hhXdRRy0EVjp6YXVhA9dOchnqxqkM9td-NiN0Fwb7MK5psxf_4-1UjKCjnRTbxm6VbEoSTpuVGbwYwmKqiZAl9mtFnYHaCpitqm6XtFeXSdhbS0nz1Qw-ptD6x-ubw-9znj69-h_jPXjA6UxOOiO3D7vLfhVfI6laujcJO7eIxhuw
  priority: 102
  providerName: Wiley-Blackwell
Title Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fagm2.12170
https://www.ncbi.nlm.nih.gov/pubmed/34553119
https://www.proquest.com/docview/2572852500
https://www.proquest.com/docview/2575830205
https://pubmed.ncbi.nlm.nih.gov/PMC8444956
https://doaj.org/article/21cbe8e833784ec3a81ad28b424d9fb7
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED6xTSBeEIxfgVEZwQtIYY3tJM4T6tDGhNSqQhRVvESO7YxJW9KlLRL_PXdOmq1i2lOj2oqc3J39-Xz5PoD3JiNQ7KIwi9UwxPW4DLXSUai5LRLERy4z9DXyeJKczuS3eTzvEm7LrqxyMyf6idrWhnLkh-haXNEZ3PDz4iok1Sg6Xe0kNHZgj6jLqKQrnafXORZC84L3rKT8UJ9dciJUIG3iG-uQp-u_DWP-Xyp5E8L6NejkMTzqwCMbtdZ-AvdctQ_3WznJv_vwYNwdlD-FZtpQIn1ZN8z0SoNLhgiVIeJj60XTatCjVVhdsgr9YXVO2vTWMY1TEd6E4apGZMfYYN0nNqn_uAu2oSB37b0K_zEQ80pHz2B2cvzjy2nYySuEBu0yDFMMXm5TjXGncZPBbZLFGtGWoddjEIehk8VWYMCaNCsR2RnjihIjXCZSJcqK57Bb1ZV7CSxVwkmRGkU1qYVEFBrZRBdR5EorcBMcwIfNy85Nxz1OEhgXecuazHMyTO4NE8C7vu-iZdy4tdcR2azvQSzZ_o-6Ocu7oMt5ZAqnnBICB-2M0CrSlqtCcmmzskgDONhYPO9Cd5lfO1oAb_tmDDo6SdGVq9e-T0zEacM4gBetg_QjETLGeS3KAki3XGdrqNst1flvT-ytpKT9agAfvZPd8fj56OuY-6tXdz_Da3jIqQrHV8UdwO6qWbs3CKNWxQB2uJwOfMQMYG_0c_Zrhr9Hx5Pp94FPTfwDf1ghcw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFL0anWC8IBgwAgOMgAeQwhrbSZwHhDbY6NhaTWiT9hYc2xmVtqSkLWh_it_ItfOxVUx721tVW5bje3x9bF-fC_BGJZYUm8BPQtH3cT3OfSlk4Euqswj5kUmUfY08HEWDI_7tODxegr_tWxgbVtn6ROeodansGfkGQosKewfX_zT55dusUfZ2tU2hUcNiz5z_wS3b9OPuF7TvW0p3tg8_D_wmq4CvsDt9P0bMUh1LhJtEbk11lIQSSYZCct5XSD9wbEPNEKcqTnIkNEqZLEdg84iLSGiG7d6CZc5wK9OD5a3t0cH3i1Mdu39gtNNBpRvy5IxaCQebDfnSyucSBFzFav8PzrxMmt2qt3Mf7jV0lWzW-HoAS6ZYhdt1AsvzVbgzbK7mH0J1UNmj-2lZEdXlNpwS5MQEOSaZT6o66z3igJQ5KRCBs3Ehz8baEInODxshuI5aeWUs0OYDGZW_zSlpRc9N3Vbmnh8Rl1vpERzdyNA_hl5RFuYJkFgww1mshI2CzTjy3kBHMgsCk2uG224P3rWDnapG7dwm3ThNa51mmlrDpM4wHrzu6k5qjY8ra21Zm3U1rC63-6OsTtJmmqc0UJkRRjCGnTaKSRFITUXGKddJnsUerLcWTxtnMU0voO3Bq64Yp7m9u5GFKeeuTmil2vqhB2s1QLqeMB6iJw0SD-IF6Cx0dbGkGP90UuKCc7tD9uC9A9k1n59ufh1S9-vp9d_wElYGh8P9dH93tPcM7lIbA-Ri8tahN6vm5jmSuFn2opk5BH7c9GT9B1wnWAQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIiouCMprSwEj4ADSkqz35T0gVCihpSTqgUq5bb22N43U7oZNAupf49cx4320EVVvvUWxZXk939if7fE3AG9UQqTYeG4Sir6L63HuSiE9V3KdRciPTKLoNfJwFO0dBd_H4XgN_rZvYSissp0T7UStS0Vn5D2EFhd0B9fv5U1YxOHu4NPsl0sZpOimtU2nUUPkwJz_we3b_OP-Ltr6LeeDrz-_7LlNhgFXYdf6boz45TqWCD2JPJvrKAklEg6FRL2vkIrgOIfaR8yqOMmR3ChlshxBHkSBiIT2sd1bcDv2Q498LB7HF-c7tJPweaeIyntycsZJzIHyIl9aA22qgKv47f9hmpfps13_BvfhXkNc2U6NtAewZopNuFOnsjzfhI1hc0n_EKrDig7x52XFVJflcM6QHTNkm2w5q8ykSRrGypwViMXFtJBnU22YxGkQG2G4opLQMhZo84GNyt_mlLXy56ZuK7MPkZjNsvQIjm5k4B_DelEW5imwWPgm8GMlKB42C5ABezqSmeeZXPu4AXfgXTvYqWp0zyn9xmlaKzbzlAyTWsM48LqrO6vVPq6s9Zls1tUghW77R1lN0sbhU-6pzAgjfB87bZQvhSc1F1nAA53kWezAdmvxtJk25ukFyB141RWjw9MtjixMubR1QhJt64cOPKkB0vXED0KcU73EgXgFOitdXS0ppidWVFwEAe2VHXhvQXbN56c734bc_tq6_htewga6aPpjf3TwDO5yCgaywXnbsL6oluY5srlF9sK6DYPjm_bTf5x3WtQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Precursor+comparisons+for+the+upregulation+of+nicotinamide+adenine+dinucleotide.+Novel+approaches+for+better+aging&rft.jtitle=Aging+medicine&rft.au=Palmer%2C+Raymond+D&rft.au=Elnashar%2C+Magdy+Mahmoud&rft.au=Vaccarezza%2C+Mauro&rft.date=2021-09-01&rft.issn=2475-0360&rft.eissn=2475-0360&rft.volume=4&rft.issue=3&rft.spage=214&rft_id=info:doi/10.1002%2Fagm2.12170&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2475-0360&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2475-0360&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2475-0360&client=summon